Cite
HARVARD Citation
Hjorth‐Hansen, H. et al. (n.d.). Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase‐2 study (NordCML006). European journal of haematology. pp. 243-250. [Online].